A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

NSCLC · NSCLC, Stage I · NSCLC Stage II · Non Small Cell Lung Cancer · Non-small Cell Lung Cancer Stage I · Non-small Cell Lung Cancer Stage II · Interstitial Lung Disease · Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Narek Shaverdian, MD) · 631-212-6323
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Narek Shaverdian, MD) · 631-212-6323
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Narek Shaverdian, MD) · 631-212-6323
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Narek Shaverdian, MD) · 631-212-6323
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Narek Shaverdian, MD) · 631-212-6323
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Narek Shaverdian, MD) · 631-212-6323
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Narek Shaverdian, MD) · 631-212-6323
Study leads
  • Narek Shaverdian, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center